在耐性乳腺癌中,细胞可塑性通过黄素的调节,向核因子kappa B信号传导
Peter Kubatka1, Lenka Koklesova2, Alena Mazurakova3
1Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia. peter.kubatka@uniba.sk.
Cancer metastasis reviews
|October 3, 2023
概括
黄类药物调节核因子kappa B (NF-κB) 信号传递,这是癌细胞可塑性和耐药性的关键因素. 这些天然化合物显示出重新敏感化疗耐药乳腺癌 (BC) 与常规疗法的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌细胞的可塑性是瘤进展,转移和治疗抵抗的主要驱动因素.
- 核因子kappa B (NF-κB) 激活是化学抵抗性乳腺癌 (BC) 的常见生物标志物.
- 准NF-κB是一种有前途的策略,可以克服癌症耐药性.
研究的目的:
- 审查黄素在调节乳腺癌中NF-κB信号传递中的作用.
- 通过向癌细胞可塑性,探索黄类药物在克服化学抵抗方面的潜力.
- 突出与常规癌症治疗相结合的黄类药物的治疗潜力.
主要方法:
- 对调查黄类药物,NF-κB信号传递和乳腺癌的研究进行文献综述.
- 通过这种分子机制的分析,类素会影响NF-κB通路和相关的细胞过程.
- 关于弗拉沃诺伊德诱导化学耐药乳腺癌细胞再敏感化的证据摘要.
主要成果:
- 黄素被认为是NF-κB信号传递的重要调节剂,对癌细胞可塑性和耐药性产生负面影响.
- 许多天然和合成的黄类药物对BC细胞中NF-κB通路产生特定干扰.
- 黄胺介导的NF-κB抑制影响瘤微环境,上皮细胞-介质细胞过渡,生长因子信号传递和其他关键通路.
结论:
- 黄类药物具有显著的潜力,通过向NF-κB来重新敏感化不响应的乳腺癌病例.
- 将传统疗法与可塑性调节的黄类药物结合起来,为癌症治疗提供了新的途径.
- 进一步评估基于黄胺的策略对于推进癌症治愈可能性至关重要.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


